-
CLSA is bullish on these two pharma stocks
Most pharma companies provided a broad roadmap on the transition to complex generic products while maintaining a calibrated R&D allocation strategy
-
Is it worth investing in the best performing Nifty stock?
Most brokerages are upbeat on Tata Steel after strong Q1FY22 performance and are of the opinion that the stock can touch Rs 1,750 in the near term
-
Should you buy SBI after it posted highest quarterly net profit of Rs 6,504 crore?
Higher slippages should be looked at in the context of no moratorium, negligible use of restructuring, already improving recoveries.
-
Should you buy, sell or hold Bharti Airtel post Q1 results?
On a sequential basis, the company's net profit declined over 62% from Rs 759.2 crore in the March quarter.
-
IndusInd Bank Q1 net profit doubles; should you buy?
A strong comeback on deposits led from retail taking CASA (Current account saving account deposits) to 42% from 40% and growing by an average of 20%.
-
Betting on Realty stocks? Here are CLSA’s top picks from the sector
Top developers aim to double their sales over the next three to four years, benefiting from strong demand, affordability and industry consolidation
-
HUL to see strong business in the second half of FY22: CLSA
HUl stock: CLSA has a buy rating on the stock with a price target of Rs 2,900 implying a 17% upside
-
CLSA gives ‘sell’ rating to Rakesh Jhunjhunwala’s gaming bet
Nazara carries a hefty scarcity premium of 3x to CLSA’s India coverage and ~10-75% even to global gaming peers
-
CLSA sees 61% upside in SBI post strong Q4 performance; should you invest?
Brokerages are upbeat on SBI due to strong asset quality and record low slippages. The bank also holds unutilized Covid provisions of ~Rs 6,300 crore.
-
Portfolio 2030: CLSA suggests these Indian stocks for Gen Z
the portfolio has four stocks — Asian Paints, FMCG players Dabur and Hindustan Unilever and QSR major Jubilant FoodWorks
